RBC Capital Reiterates Outperform Rating on Karyopharm Therapeutics (KPTI)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 0.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.88 | 52 Week High | $19.41 | |||
| Open | $0.88 | 52 Week Low | $4.83 | |||
| Day High | $0.88 | P/E | N/A | |||
| Day Low | $0.88 | EPS | $-2.74 | |||
| Volume | 152,924 | |||||
